CVS Health Corporation
NYSECVS Health reported its Q2 results on August 5 and the immediate verdict from the market is a 4.5% weekly loss, even as the analyst community keeps its targets well above where the stock now trades. The price action tells the story plainly. CVS closed Tuesday at $104.42, down 0.9% on the day and down 4.5% on the week. That erases some of the year-to-date recovery, though the stock…
CVS short interest surged 13% to 1.94% of float in one day, marking a 26% jump over the past week as bears build positions ahead of August earnings.
CVS Health reported its Q2 results on August 5 and the immediate verdict from the market is a 4.5% weekly loss, even as the analyst community keeps its targets well above where the stock now trades. The price action…
CVS Health heads into its August 5 earnings release with the strongest analyst tailwind it has seen in months, trading at $104.43 against a consensus target of $113.50. The analyst setup is unusually constructive.…
Snapshot as of 6 Aug 2026
CVS Health has done something awkward this week — it outran the Street's targets. Since the last note published on July 8, two more firms lifted their price targets. Truist Securities raised to $118 on July 14. Wells…
CVS Health heads into its August 5 earnings with the Street in unusually unanimous agreement — and the stock trading within a few dollars of where the bulls want it. The analyst upgrade cycle has been relentless. Every…
CVS Health has given back a little ground this week, but the narrative from the Street continues to move in one direction: higher. The stock dipped 1.9% on Tuesday to close at $94.18, trimming its weekly gain to -1.0%.…
CVS Health has just delivered its biggest weekly gain in years — up 18% — and the analyst community has responded with a rare, almost unanimous round of target-price upgrades. The week's most compelling story is not…
CVS Health enters its May 14 earnings report carried by a wave of analyst upgrades that has reset expectations sharply higher heading into the print. The most striking pre-earnings signal is from the Street, where at…
CVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story…
CVS Health reports Q1 2026 results on May 6 as a stock that has quietly re-rated higher — and with the short sellers who drove much of the bearish narrative now stepping back. Short interest has fallen sharply over the…
CVS Health enters its May 6 earnings call in a notably better place than it left the last few months — up 15.5% over the past month and shedding short positions at pace, yet options traders are quietly loading up on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVS — free to start on ORTEX.
Sign up for free →Open CVS on ORTEX